Dr. David Wood is a Professor of Medicine at the University of British Columbia
Dr. David Wood is a Professor of Medicine at the University of British Columbia. He is the Head of the
Division of Cardiology and the Medical Director for the Cardiac Sciences Program at Vancouver Coastal
Health. He is the inaugural Director of the Centre for Cardiovascular Innovation – Centre d’Innovation
Cardiovasculaire (CCI-CIC), a clinical research operation centre with 39 affiliated staff and 72
cardiovascular investigators in British Columbia. Dr. Wood is the President of the Canadian Association
of Interventional Cardiology (CAIC-ACCI). He received the Luminary Award at the recent C3 Global
Submit. He is the Course Director of the CAIC-ACCI Summit, an open Canadian forum to discuss
controversies in complex coronary and structural heart disease interventions.
Dr. Wood works as a structural and interventional cardiologist at St. Paul’s and Vancouver General
Hospital. He obtained subspecialty training at Lenox Hill Heart and Vascular Institute of New York. His
primary research interests include transcatheter management of structural and valvular heart disease,
new device development, novel strategies for treating ACS, and advanced cardiac imaging. Dr. Wood has
participated in over 50 live-cases and 20 first-in-human cases. He has co-authored over 200 publications
with an h-index of 74. He recently published the 3M TAVR Study (JACC CVI), the SAFE MANTA Study (Circ
CVI), and was co-principal investigator of the CIHR funded COMPLETE trial (4,041 patients, 140 centres,
31 countries) that was presented as Late Breaking Science at both ESC and TCT with simultaneous
publication in NEJM and JACC. He is currently PI of the COMPLETE TAVR trial (n = 4000, 103 centres), the
DISCORDANCE TAVR study (n = 50, 11 centres), the ULTRA CLOSURE study (n = 250, 7 centres), and the
PROTECT TAVR study (n = 200, 15 centres). In May 2020, in collaboration with 15 North American
Cardiovascular Society Leaders representing over 90,000 clinicians, he simultaneously published Safe
Reintroduction of Cardiovascular Services During the COVID-19 Pandemic in JACC, CJC, and the ATS.